Indomethacin Treatment of Mice with Premalignant Oral Lesions Sustains Cytokine Production and Slows Progression to Cancer
Current treatment options for head and neck squamous cell carcinoma (HNSCC) patients are often ineffective due to tumor localized and systemic immunosuppression. Using the 4-NQO mouse model of oral carcinogenesis, this study showed that premalignant oral lesion cells produce higher levels of the im...
Main Authors: | Sara D. Johnson, M. Rita I. Young |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00379/full |
Similar Items
-
Cytokine and Adipokine Levels in Patients with Premalignant Oral Lesions or in Patients with Oral Cancer Who Did or Did Not Receive 1α,25-Dihydroxyvitamin D3 Treatment upon Cancer Diagnosis
by: M. Rita I. Young, et al.
Published: (2015-06-01) -
Effect of the Premalignant and Tumor Microenvironment on Immune Cell Cytokine Production in Head and Neck Cancer
by: Sara D. Johnson, et al.
Published: (2014-04-01) -
DNA Methylome Distinguishes Head and Neck Cancer from Potentially Malignant Oral Lesions and Healthy Oral Mucosa
by: Nina Milutin Gašperov, et al.
Published: (2020-09-01) -
Oxidative Imbalance And Risk Factors Involved In Premalignant And Malignant Lesions Of The Uterine Cervix
by: Danay Heredia-Ruiz, et al.
Published: (2019-05-01) -
Assessment of the oral health seeking behavior of patients with premalignant lesions
by: Shravani G Deolia, et al.
Published: (2020-01-01)